195 related articles for article (PubMed ID: 29101624)
1. Genistein attenuates pathological cardiac hypertrophy in vivo and in vitro.
Meng Y; Zhang Y; Ma Z; Zhou H; Ni J; Liao H; Tang Q
Herz; 2019 May; 44(3):247-256. PubMed ID: 29101624
[TBL] [Abstract][Full Text] [Related]
2. Myricetin Alleviates Pathological Cardiac Hypertrophy via TRAF6/TAK1/MAPK and Nrf2 Signaling Pathway.
Liao HH; Zhang N; Meng YY; Feng H; Yang JJ; Li WJ; Chen S; Wu HM; Deng W; Tang QZ
Oxid Med Cell Longev; 2019; 2019():6304058. PubMed ID: 31885808
[TBL] [Abstract][Full Text] [Related]
3. RIP2 deficiency attenuates cardiac hypertrophy, inflammation and fibrosis in pressure overload induced mice.
Zhao CH; Ma X; Guo HY; Li P; Liu HY
Biochem Biophys Res Commun; 2017 Nov; 493(2):1151-1158. PubMed ID: 28698147
[TBL] [Abstract][Full Text] [Related]
4. Asiatic acid attenuates cardiac hypertrophy by blocking transforming growth factor-β1-mediated hypertrophic signaling in vitro and in vivo.
Si L; Xu J; Yi C; Xu X; Wang F; Gu W; Zhang Y; Wang X
Int J Mol Med; 2014 Aug; 34(2):499-506. PubMed ID: 24827470
[TBL] [Abstract][Full Text] [Related]
5. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L
Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234
[TBL] [Abstract][Full Text] [Related]
6. DKK3 overexpression attenuates cardiac hypertrophy and fibrosis in an angiotensin-perfused animal model by regulating the ADAM17/ACE2 and GSK-3β/β-catenin pathways.
Zhai CG; Xu YY; Tie YY; Zhang Y; Chen WQ; Ji XP; Mao Y; Qiao L; Cheng J; Xu QB; Zhang C
J Mol Cell Cardiol; 2018 Jan; 114():243-252. PubMed ID: 29196099
[TBL] [Abstract][Full Text] [Related]
7. Puerarin attenuates pressure overload-induced cardiac hypertrophy.
Yuan Y; Zong J; Zhou H; Bian ZY; Deng W; Dai J; Gan HW; Yang Z; Li H; Tang QZ
J Cardiol; 2014 Jan; 63(1):73-81. PubMed ID: 23906530
[TBL] [Abstract][Full Text] [Related]
8. Qiliqiangxin Attenuates Phenylephrine-Induced Cardiac Hypertrophy through Downregulation of MiR-199a-5p.
Zhang H; Li S; Zhou Q; Sun Q; Shen S; Zhou Y; Bei Y; Li X
Cell Physiol Biochem; 2016; 38(5):1743-51. PubMed ID: 27161004
[TBL] [Abstract][Full Text] [Related]
9. BRD4 blockage alleviates pathological cardiac hypertrophy through the suppression of fibrosis and inflammation via reducing ROS generation.
Zhu W; Wu RD; Lv YG; Liu YM; Huang H; Xu JQ
Biomed Pharmacother; 2020 Jan; 121():109368. PubMed ID: 31707348
[TBL] [Abstract][Full Text] [Related]
10. Nobiletin, a Polymethoxy Flavonoid, Protects Against Cardiac Hypertrophy Induced by Pressure-Overload via Inhibition of NAPDH Oxidases and Endoplasmic Reticulum Stress.
Zhang N; Wei WY; Yang Z; Che Y; Jin YG; Liao HH; Wang SS; Deng W; Tang QZ
Cell Physiol Biochem; 2017; 42(4):1313-1325. PubMed ID: 28700997
[TBL] [Abstract][Full Text] [Related]
11. JIP3 deficiency attenuates cardiac hypertrophy by suppression of JNK pathway.
Ma Q; Liu Y; Chen L
Biochem Biophys Res Commun; 2018 Sep; 503(1):1-7. PubMed ID: 29604277
[TBL] [Abstract][Full Text] [Related]
12. Plantamajoside attenuates isoproterenol-induced cardiac hypertrophy associated with the HDAC2 and AKT/ GSK-3β signaling pathway.
Shang L; Pin L; Zhu S; Zhong X; Zhang Y; Shun M; Liu Y; Hou M
Chem Biol Interact; 2019 Jul; 307():21-28. PubMed ID: 31009642
[TBL] [Abstract][Full Text] [Related]
13. Cardiac-specific mindin overexpression attenuates cardiac hypertrophy via blocking AKT/GSK3β and TGF-β1-Smad signalling.
Yan L; Wei X; Tang QZ; Feng J; Zhang Y; Liu C; Bian ZY; Zhang LF; Chen M; Bai X; Wang AB; Fassett J; Chen Y; He YW; Yang Q; Liu PP; Li H
Cardiovasc Res; 2011 Oct; 92(1):85-94. PubMed ID: 21632881
[TBL] [Abstract][Full Text] [Related]
14. Alpha Mangostin Derived from Garcinia magostana Linn Ameliorates Cardiomyocyte Hypertrophy and Fibroblast Phenotypes in Vitro.
Sari N; Katanasaka Y; Sugiyama Y; Miyazaki Y; Sunagawa Y; Funamoto M; Shimizu K; Shimizu S; Hasegawa K; Morimoto T
Biol Pharm Bull; 2021; 44(10):1465-1472. PubMed ID: 34602555
[TBL] [Abstract][Full Text] [Related]
15. [Overexpression of miR-130a-3p attenuates cardiomyocyte hypertrophy].
Wang X; Qu J; Li D; Li J; Wu W; Liu X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2020 Apr; 37(2):340-348. PubMed ID: 32329288
[TBL] [Abstract][Full Text] [Related]
16. Cardiomyocyte-restricted inhibition of G protein-coupled receptor kinase-3 attenuates cardiac dysfunction after chronic pressure overload.
von Lueder TG; Gravning J; How OJ; Vinge LE; Ahmed MS; Krobert KA; Levy FO; Larsen TS; Smiseth OA; Aasum E; Attramadal H
Am J Physiol Heart Circ Physiol; 2012 Jul; 303(1):H66-74. PubMed ID: 22542621
[TBL] [Abstract][Full Text] [Related]
17. Maslinic acid protects against pressure overload-induced cardiac hypertrophy in mice.
Liu YL; Kong CY; Song P; Zhou H; Zhao XS; Tang QZ
J Pharmacol Sci; 2018 Oct; 138(2):116-122. PubMed ID: 30389277
[TBL] [Abstract][Full Text] [Related]
18. Shensongyangxin protects against pressure overload‑induced cardiac hypertrophy.
Shen DF; Wu QQ; Ni J; Deng W; Wei C; Jia ZH; Zhou H; Zhou MQ; Bian ZY; Tang QZ
Mol Med Rep; 2016 Jan; 13(1):980-8. PubMed ID: 26648261
[TBL] [Abstract][Full Text] [Related]
19. Dual-specificity phosphatase 14 protects the heart from aortic banding-induced cardiac hypertrophy and dysfunction through inactivation of TAK1-P38MAPK/-JNK1/2 signaling pathway.
Li CY; Zhou Q; Yang LC; Chen YH; Hou JW; Guo K; Wang YP; Li YG
Basic Res Cardiol; 2016 Mar; 111(2):19. PubMed ID: 26891723
[TBL] [Abstract][Full Text] [Related]
20. Nuclear Localization Leucine-Rich-Repeat Protein 1 Deficiency Protects Against Cardiac Hypertrophy by Pressure Overload.
Zong J; Li FF; Liang K; Dai R; Zhang H; Yan L; Liu JL; Xu LH; Qian WH
Cell Physiol Biochem; 2018; 48(1):75-86. PubMed ID: 30001530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
